Skip to main content

FDA to Reduce and Phase Out Animal Testing! – What You Need to Prepare!

Mark Scott
July 26, 2025

Over 90% of the drugs that appear safe and effective in animals do not receive FDA clearance for humans. In April 2025, the United States Food and Drug Administration announced a Roadmap to Reducing Animal Testing in Preclinical Safety Studies. The FDA intends to reduce and phase out animal testing and promote alternatives such as […]

Read More

5 Important Rules for Successful Culturing of Primary Cells!

Mark Scott
June 6, 2025

Cell Applications has released a new Short video with 5 Important Rules for Successful Culturing of Primary Cells! Primary cells maintain physiological relevance (cell morphology, growth patterns, and responses to stimuli) and are able to better represent in vivo conditions. Primary cells are isolated directly from tissues and retain the characteristics of their origin, and […]

Read More

Cell Applications Overview Video Updated

Mark Scott
June 3, 2025

Cell Applications is proud to re-introduce our overview video, which highlights our expertise in primary cells. This update includes exciting cell video and images, along our new address with pictures of the new building. We also invite you shop this Cell Applications website to see the full breadth of products and services to support your […]

Read More

Cell Applications Overview Video in Vertical Format Short Version

Mark Scott
May 16, 2025

Cell Applications is proud to introduce our overview video in vertical format short version which is optimized for viewing on mobile screens and highlights our expertise in primary cells. We also invite you visit the Cell Applications website to see the full breadth of products and services to support your cell research.

Read More
HUVEC

Nature recently published research from the Translational Cancer Medicine Program at the University of Helsinki, Finland

Mark Scott
April 15, 2025

nature communications Nature Communications, a peer-reviewed journal from Nature recently published research from the Translational Cancer Medicine Program at the University of Helsinki, Finland that provided insights on the dynamic regulation of lymphatic capillary endothelial cells in the context of lung metastasis. Human Umbilical Vein Endothelial Cells (HUVEC) from Cell Applications, Inc were used in […]

Read More
Brown Fat Preadipocytes (i-HBrPAd)

Celebrating 30 Years of Innovation: Cell Applications Unveils Groundbreaking Brown Fat Cells

Mark Scott
November 23, 2024

Until now, studying human brown fat was nearly impossible due to its extreme scarcity in adults. For the first time, Cell Applications makes Brown Fat Preadipocytes available. SAN DIEGO–(BUSINESS WIRE)–Cell Applications, Inc. is pioneering a new era with the release of Brown Fat Preadipocytes (i-HBrPAd), a first-of-its-kind cellular model derived from pluripotent stem cells and cryopreserved […]

Read More
Hammond Cell Tech Logo

Hammond Cell Tech is now part of Cell Applications

Mark Scott
December 17, 2019

Cell Applications, Inc. is proud to announce the acquisition of Hammond Cell Tech. Founded in 1988 by Susan Hammond, Hammond Cell Tech developed and optimized proprietary technologies to manufacture highly stable, non-lyophilized extracts with consistent activity, and has supported the research community for over 30 years. Cell Applications will continue the tradition of providing high […]

Read More

Airway Cells Breathe Life into Lung Research

Mark Scott
March 1, 2017

Human Small Airway Epithelial Cells and Specialized Media added to Lung Cell Portfolio  SAN DIEGO, Mar 1, 2017 — To further support life science research and pharmaceutical drug discovery for crippling pulmonary diseases, Cell Applications, Inc. has expanded its lung cell portfolio with the addition of Human Small Airway Epithelial Cells and optimized Growth Media.  HSAEpC […]

Read More

Human iPSC-Derived Neural Stem Cells Introduced for Research

Mark Scott
November 13, 2016

SAN DIEGO, Nov 13, 2016 — Officials at Cell Applications, Inc. announce the launch of a unique model to study neural development, neurotoxicity, differentiation, electrophysiology and disease.  Human iPSC-Derived Neural Stem Cells (i-HNSC) are a homogeneous, self-renewing and multipotent population derived from Human Induced Pluripotent Stem Cells (HiPSC). Through partnership with leading stem cell company StemoniX, i-HNSC, and cells derived from them, […]

Read More

Perineurial Fibroblasts and Schwann Cells Introduced at CA

Mark Scott
October 16, 2016

SAN DIEGO, Oct 26, 2016 — Today Cell Applications, Inc. announces the addition of two key Primary Cells of the nervous system: Rat Perineurial Fibroblasts (RPF) and Rat Schwann Cells (RSC), paired with their corresponding, optimized Media. RPF form a connective tissue compartment of the peripheral nerve called the perineurium, which wraps around fascicles to form a diffusion barrier. The perineurium protects […]

Read More